Discover 224 paid clinical trials in Albany, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 224
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
for
Aortic Stenosis
Location: Albany NY, New York NY, Boston MA, Summit NJ, Quebec,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT05646381
Phase2, Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Albany NY, Hartford CT, New Haven CT, Bridgeport CT,
Sponsor: Cytokinetics
Sex: All
Age: 18 - 70+
Code: NCT06736574
Phase3, Recruiting
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
for
Heart Failure - NYHA II - IV
Location: Albany NY, Syracuse NY, New York NY, Flushing NY,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07069738
Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Albany NY, New York NY, Providence RI, Scarborough ME,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Albany NY, Springfield MA, Hartford CT, New Britain CT,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Mobility Opportunities Via Education/Experience (MOVE): Healthcare Impact Assessment
for
Quality of Life, Health Care Utilization
Location: Albany NY
Sponsor: Center for Disability Services, New York
Sex: All
Age: 5 - 65
Code: NCT05862662
Recruiting
New
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis (UC), Severe Ulcerative Colitis,
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
for
Mild Cognitive Impairment
Location: Menands NY, New York NY
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 55+
Code: NCT05016219
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Albany NY, Clifton Park NY, Nyack NY, Montreal,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222566
Phase3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Albany NY, The Bronx NY, East Brunswick NJ,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase2, Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Albany NY, New Haven CT, Stony Brook NY, New York NY,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase3, Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Albany NY, New Haven CT, Lebanon NH, Paramus NJ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase3, Recruiting
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Albany NY, White Plains NY, Norwich CT,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
for
HER2-negative, Gastroesophageal Junction,
Location: Albany NY, New York NY, Boston MA
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07546812
Phase2, Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer